Medtronic Hugo Robotic IDE Trial
Robotic-assisted surgery reduces surgical trauma, minimises complications and shortens hospitalisation compared to open techniques.
The Medtronic Embrace Gynecology US investigational device exemption (IDE) study evaluates the safety and effectiveness of the Hugo robotic-assisted surgery (RAS) system in gynaecological procedures.
The study aims to validate an integrated surgical ecosystem that combines robotics, imaging, instrumentation and workflow optimisation to enhance precision, consistency and efficiency in women’s health interventions.
The Hugo system is designed to deliver a unified platform integrating robotic control, procedural planning and device interoperability.
Author's summary: Medtronic's Hugo RAS system enhances gynaecology surgery precision.